The AIFM3 gene helps cells manage energy inside mitochondria and take part in apoptosis, the built in process that removes damaged or unwanted cells. If this gene does not work as expected, normal cell turnover may be less well controlled, which can affect how tissues stay balanced and healthy. Researchers are studying the AIFM3 gene because altered activity has been linked to some cancers, where it may influence how cells survive or die.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Others mostly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they may also influence how you respond to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
AIFM3Gene function
What if the gene works
The AIFM3 gene helps make a protein in mitochondria, the parts of cells that produce energy. This protein may help regulate programmed cell death, a normal process that removes damaged cells.
Risk
What if the gene does not work
Changes in the AIFM3 gene can range from milder to more severe and may reduce how well cells carry out a mitochondria related cell death pathway. This can alter normal stress signaling inside cells.
Treatment
What does that mean for your treatment
No AIFM3-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the AIFM3 gene. The AIFM3 gene is being studied in cancer research as a possible biomarker linked to cell death pathways, but this does not currently guide routine drug choices.
Gene function
What if the gene works
Inside many cells, AIFM3 is active in mitochondria, the structures that help manage energy. Its main job is to support programmed cell death, a normal process your body uses to remove cells in a controlled way. Understanding how the AIFM3 gene works helps make sense of routine cell maintenance and renewal.
AIFM3 helps cells carry out programmed cell death, which is the body’s controlled way of removing cells that are old or no longer needed. This supports normal tissue renewal and balance.
Its protein works mainly in mitochondria, the parts of cells that help manage energy. From there, it connects normal mitochondrial activity with the signals that guide orderly cell turnover.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AIFM3 gene can change the protein’s shape, stability, or movement inside the cell, which may weaken its interactions at the mitochondria and its role in controlled cell death. This helps explain how AIFM3 gene variants affect protein function in cells. Some variants may only partly reduce activity, while more severe variants can lead to very little working protein or keep it from reaching the right place in the cell.
How variants are linked to conditions
At present, AIFM3 gene variants and health conditions do not have a broadly confirmed one-to-one link in human genetics, and research is still evolving. If you carry a change in the AIFM3 gene or have an AIFM3-related result on genetic testing, your doctor or genetic counselor can explain what it may mean in the context of your own health and family history.
A variant is not necessarily a diagnosis
Variants are a usual feature of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a certain diagnosis, particularly when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the AIFM3 gene. Anyone with questions about their personal or family risk can talk with a doctor or genetic counselor.
Inheritance of AIFM3 variants
For people looking into how AIFM3 gene variants are inherited, there is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific AIFM3 related condition. Research on this gene is still developing, so inheritance may be clarified further over time. The AIFM3 gene is located on chromosome 22, which is an autosome, so each person inherits one copy of the AIFM3 gene from each parent.
What does my AIFM3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for AIFM3, although this may become clearer as research grows. If you have a specific AIFM3 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find variants, genetic testing for AIFM3 variants reads the AIFM3 gene from a blood, saliva, or cheek swab sample. A lab checks the gene's DNA sequence for changes and reports whether a variant was found, which can help clarify whether this gene is involved.
When should I consider getting a genetic test?
There isn't yet a broadly established, AIFM3-specific clinical reason for testing. Decisions about genetic testing are usually based on your personal health and family history and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and on the type of variant involved. Over time, factors like lifestyle, environment, age, and medical history all influence how the body functions. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, so the same treatment may work better for one person than for another. This is common and can influence both how much benefit a medicine provides and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medicines. By studying the relationship between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many drugs, genes influence both how strongly a medicine works and how the body processes it. This understanding can support treatment decisions that are more informed and more personalized. More information on this topic is available in the LearnHub.
Drugs influenced by the AIFM3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general questions about treatment, side effects, or medicine changes are best discussed with your doctor. Seek medical advice if you have unexpected side effects or if a treatment does not seem to be helping.
History
In recent decades, awareness of the AIFM3 gene’s role has grown. It was identified during research into genes related to cell death, a normal process the body uses to remove damaged cells. Early laboratory studies placed AIFM3 within a small family of genes that drew attention for their possible role in cancer biology. From these first observations, research expanded steadily. Later work examined how changes in AIFM3 activity might be linked with tumor growth in several tissues, which helped move it from a basic research finding into a gene of clinical interest. Its history is mainly a scientific one, shaped by gradual discoveries rather than a single widely known public event.